Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lung clearance index response in patients with CF with class III CFTR mutations.

Thorax - 1 May 2016

Kane Mica, Gonska Tanja, Jensen Renee, Avolio Julie, Klingel Michelle, Stanojevic Sanja, Ratjen Felix

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator
Share to Forced Expiratory Volume

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Quinolones

Share to Severity of Illness Index

Share to Spirometry

Share to Treatment Outcome

Source

Identifiers

PMID: 26944510
DOI: 10.1136/thoraxjnl-2015-207894

Genes

CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Lung clearance index response in patients with CF with class III CFTR mutations.PMID 26944510Read ↗

Lung Clearance Index as a definitive surrogate endpoint for therapeutic interventions in cystic fibrosisSemantic proximity Read ↗

Changes in LCI in F508del/F508del patients treated with lumacaftor/ivacaftor: Results from the prospect study.Semantic proximity Read ↗

Lung clearance index to characterize clinical phenotypes of children and adolescents with cystic fibrosis.Semantic proximity Read ↗

Outcome measures for cystic fibrosis gene therapy clinical trialsSemantic proximity Read ↗

Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial.Semantic proximity Read ↗

Cystic fibrosis gene mutations: evaluation and assessment of disease severitySemantic proximity Read ↗

Treating the Airway Consequences of Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction.Semantic proximity Read ↗

Airway clearance and exercise for people with cystic fibrosis: Balancing longevity with life.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.